• SW033291: 15-PGDH Inhibitor Workflows in Regeneration Resear

  2026-08-03

  SW033291 redefines 15-PGDH inhibitor workflows by enabling robust prostaglandin E2 elevation and precise control over tissue regeneration, muscle repair, and hematopoietic stem cell expansion. Its nanomolar potency, validated across enzyme, cell, and in vivo models, makes it the gold standard for applied regeneration research.

• Cefoperazone (sodium salt): Reliable Antibacterial Assay Res

  2026-08-03

  This article addresses practical laboratory challenges in antimicrobial research, offering scenario-driven guidance on using Cefoperazone (sodium salt) (SKU C3913) for reproducible, β-lactamase-stable results. Readers gain evidence-based strategies for protocol optimization, data interpretation, and product selection, grounded in both literature and the chemical’s core properties.

• Non-Proteolytic K29-Ubiquitination Fine-Tunes Plant Immunity

  2026-08-02

  This study uncovers how the E3 ligase IPI7 mediates non-proteolytic K29-linked ubiquitination of the IPA1 transcription factor, enabling fine control of rice immune responses to Magnaporthe oryzae without compromising growth. The findings reveal a novel regulatory layer in plant immunity with implications for targeted crop improvement.

• Early Life Adversity Impairs Innate Defense via Oxytocin Pat

  2026-08-01

  Tan et al. reveal that early life adversity impairs visually evoked innate defensive behaviors in mice through disruption of oxytocin signaling within the superior colliculus. This neurobiological insight connects early environmental stress to altered threat processing, offering a mechanistic link to later psychopathological risk.

• SU5416 (Semaxanib): Precision Inhibition of VEGFR2 in Cancer

  2026-07-31

  SU5416 (Semaxanib) is a selective VEGFR2 inhibitor that robustly suppresses VEGF-driven angiogenesis and tumor vascularization. Its high specificity and dual role as an aryl hydrocarbon receptor agonist make it a versatile tool for cancer and immune modulation studies. APExBIO provides validated protocols and extensive support for reproducible research applications.

• MLN8237 (Alisertib): Precision Aurora A Inhibition in Cancer

  2026-07-31

  MLN8237 (Alisertib) is a highly selective Aurora A kinase inhibitor that enables precise interrogation of mitotic control, apoptosis induction, and tumor growth inhibition in advanced cancer biology workflows. Its nanomolar potency, favorable selectivity, and compatibility with diverse assay formats make it a cornerstone for both mechanistic and translational oncology studies.

• Cy5 amine (non-sulfonated): Technical Guidance and Protocols

  2026-07-30

  Cy5 amine (non-sulfonated) provides a highly photostable, bright fluorophore for covalent labeling of proteins, polymers, or nucleic acids in research workflows where water solubility is not required. It solves problems associated with water-insoluble dyes for sensitive fluorescence detection in microscopy, flow cytometry, and molecular imaging. Direct aqueous labeling or any diagnostic use is not recommended.

• Olive Biophenols Reduce Amyloid Pathology in AD Models

  2026-07-30

  This study demonstrates that olive-derived biophenols, particularly oleuropein, verbascoside, and rutin, significantly inhibit amyloid beta aggregation and protect neuronal cells from amyloid-induced toxicity in both cellular and mouse models of Alzheimer's disease. These findings highlight the therapeutic potential of natural biophenols in modifying disease progression and encourage further mechanistic and translational research.

• AptaBLE: Deep Learning Advances Aptamer–Protein Interaction

  2026-07-29

  AptaBLE introduces a deep learning platform that predicts and generates aptamer sequences for specific protein binding, overcoming longstanding biases and inefficiencies in conventional SELEX-based discovery. This approach demonstrates improved accuracy and generalization, enabling more rapid and cost-effective development of aptamer therapeutics and diagnostics.

• Analytical Advances for Rotigotine in PD Research and Formul

  2026-07-29

  This review systematically evaluates analytical methods for assessing rotigotine and its impurities in both raw materials and pharmaceutical formulations, with a focus on quality control for Parkinson’s disease and restless legs syndrome therapies. Key innovations include detailed comparison of validated chromatographic techniques and regulatory standards, providing a foundation for improved formulation stability and impurity monitoring.

• Elbasvir/Grazoprevir: Advancing HCV Genotype 1 and 4 Treatme

  2026-07-28

  The referenced review systematically evaluates the pharmacology, efficacy, and safety of the elbasvir and grazoprevir fixed-dose combination for hepatitis C virus (HCV) infection. The study highlights its robust performance across genotypes 1 and 4, including in patients with renal impairment or challenging comorbidities, and underscores its high barrier to resistance and favorable tolerability profile.

• Palonosetron Hydrochloride: Advances in CINV Prevention

  2026-07-28

  Ruhlmann and Herrstedt’s review establishes palonosetron hydrochloride as a next-generation 5-HT3 receptor antagonist with distinctive pharmacological and clinical advantages for chemotherapy-induced nausea and vomiting (CINV). The study highlights its prolonged efficacy, especially for delayed emesis, and positions palonosetron as superior to earlier agents, supporting optimized antiemetic regimens in oncology.

• EPZ5676: Precision DOT1L Inhibitor Workflows for Epigenetic

  2026-07-27

  EPZ5676 revolutionizes epigenetic studies with its unmatched potency and selectivity as a DOT1L inhibitor, enabling precise H3K79 methylation assays and targeted MLL-rearranged leukemia research. This guide delivers protocol optimization, troubleshooting strategies, and practical insights for maximizing reproducibility and data quality in advanced experimental workflows.

• MG-132 (Z-LLL-al): Protocol Advances for Apoptosis & Cell Cy

  2026-07-27

  MG-132 (Z-LLL-al) stands out for its precision in apoptosis and cell cycle arrest assays, enabling researchers to dissect ubiquitin-proteasome system dynamics with high reproducibility. This article delivers workflow enhancements, troubleshooting insights, and actionable recommendations for maximizing MG-132's impact, anchored by the latest research and protocol innovations.

• Carbohydrate-Decorated Nanoparticles Enable Macrophage Gene

  2026-07-26

  This study demonstrates that biodegradable nanoparticles decorated with specific carbohydrates, such as mannose and dextran, significantly enhance targeted gene delivery to macrophages—a cell type historically resistant to transfection. The findings provide a platform for more precise gene regulation and therapeutic intervention in diseases involving macrophage dysregulation.

449 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page